Announced Fri, 15 May · 19:45 IST

InvInvestor Presentation for the quarter and year ended March 31, 2026estor Presentation

Investor Communications View source PDF

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹1323.00
prior close
₹1335.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-2.2-2.6-2.9+1.2-0.2-1.2+2.7+2.6+0.2+1.5+1.9+17.8
Up moveDown movePending
AI summary

Jupiter Life Line Hospitals reported FY26 total income of Rs 1,499.8 Cr, up 15.2% YoY, with EBITDA of Rs 343.3 Cr (23.0% margin). PAT stood at Rs 194.2 Cr, flat YoY due to higher depreciation (Rs 87.6 Cr vs Rs 57.1 Cr), increased finance costs (Rs 32.7 Cr vs Rs 10.7 Cr), and new labour code impact. The Dombivli hospital was operationalized on Feb 25, 2026, ahead of schedule, incurring Rs 9.4 Cr ramp-up losses. The company completed BKC land acquisition (Rs 354 Cr for 80-year lease) for a 400-bed multispecialty quaternary care hospital. Expansion pipeline includes Pune II (500 beds) and Mira-Bhayandar (300 beds), targeting total bed capacity of 2,900 beds. Gross debt increased to Rs 500.9 Cr (vs Rs 321.7 Cr) to fund ongoing capex.

Likely market impact

Flat PAT growth despite strong revenue indicates near-term margin pressure from new hospital ramp-ups and higher debt costs. However, the ahead-of-schedule Dombivli launch and strategic BKC acquisition position the company for long-term growth in the MMR region.